Clinical Trials Browser

Phase 1/2 × Sexually Transmitted Diseases × 90 days × Clear all

NCT06491446 2026-02-18

Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

Phase 1/2 Active not recruiting

Sexually Transmitted Diseases, Papillomavirus Infections